This bill amends the Public Health Service Act to formally define "short-term limited duration insurance" (STLDI) as health insurance plans with contracts expiring within 12 months of their start date. It allows these plans to include renewal options without premium increases based on health status. The definition directly affects health insurance issuers selling STLDI and consumers purchasing these temporary coverage options. This change creates a clear regulatory category for short-term plans but does not alter their availability or requirements beyond the defined terms.
This bill requires hospitals to screen all infants under 21 days old for congenital cytomegalovirus (CMV), a common viral infection that can cause hearing loss and developmental delays. It directs state health officials to establish screening standards and procedures, with the federal Advisory Committee stepping in if states fail to act within two years of the law's enactment. The bill authorizes funding through the Health Resources and Services Administration, Centers for Disease Control and Prevention, and National Institutes of Health to support state screening programs, data systems, healthcare provider training, and research on CMV screening and treatments. These provisions directly affect newborns in hospitals, healthcare providers administering tests, and state public health agencies implementing the screening requirements.
HR 4903, the Plastic Health Research Act, directs federal agencies to fund and coordinate research on the health effects of plastic exposure, including microplastics and nanoplastics. It authorizes $10 million annually (2026-2030) for grants to academic institutions and nonprofits to develop standardized testing methods, improve research comparability, and fill gaps in understanding plastic-related health impacts. The bill also creates "Centers of Excellence" to advance this research, requiring annual public reports on findings and coordination with agencies like the EPA and FDA. This legislation directly affects researchers, federal health agencies, and public health policy by prioritizing scientific rigor in studying plastic exposure sources (e.g., food packaging, waste disposal) and health outcomes.
This bill creates a new tax-exempt status ("public interest drug or medical device health care organization") for nonprofit organizations that manufacture or distribute affordable drugs and medical devices. To qualify, organizations must primarily focus on making eligible drugs/devices affordable (addressing shortages, unmet health needs, or public health emergencies), avoid conflicts with for-profit manufacturers, and meet strict board composition rules. Key provisions require organizations to agree to prioritize supplying designated drugs/devices to the federal strategic stockpile at cost during emergencies. The bill directly affects qualifying nonprofits seeking tax exemption, not patients or healthcare providers.
S 1394, the Expanding Access to Family Planning Act, provides federal funding to support clinics offering family planning services under Title X of the Public Health Service Act. It allocates $512 million annually (2026-2035) for grants to clinics and $50 million for clinic infrastructure like construction and equipment. The bill requires clinics receiving this funding to provide nondirective pregnancy counseling, ensuring patients receive neutral information about all options - including prenatal care, adoption, and pregnancy termination - with referrals upon request. This directly affects Title X clinics and their patients by increasing financial support and mandating specific counseling standards.
HR 6989, the Public Health Nursing Act, provides $5 billion annually (2026-2035) to expand the public health nursing workforce through grants to state, local, and territorial health departments. It directly affects underserved communities by funding the recruitment, hiring, and training of registered nurses in areas with high chronic disease rates, maternal mortality, low-income populations, or rural settings. Key provisions require grant recipients to use funds for nurse wages, medical supplies (like PPE), and administrative costs, while prioritizing services for medically underserved groups and culturally appropriate care. The bill also mandates maintaining pre-grant funding levels and defines public health nurses as those providing preventive care, maternal health services, and chronic disease management.
This bill creates a new Office of Rural Health within the Centers for Disease Control and Prevention (CDC) to address healthcare needs in rural communities. The office will coordinate CDC research, develop policies, and award grants focused on improving rural health access - particularly through telehealth - while identifying healthcare gaps and disparities. It directly affects rural populations by targeting challenges like chronic disease prevention, injury prevention, and limited care access. The office will work across CDC programs and coordinate with other federal health agencies to avoid duplicating efforts on rural health initiatives.
S 3604, the Public Health Nursing Act, establishes a $5 billion annual federal grant program (2026-2035) to expand public health nursing services. It provides funding to state, local, and territorial health departments to hire and train registered nurses, particularly in medically underserved areas with high rates of chronic disease, maternal mortality, or low-income populations. Funds cover nurse wages, training, medical supplies, and administrative costs, with priority given to applicants serving rural communities, health professional shortage areas, and populations requiring culturally appropriate care. Recipients must maintain their own funding levels for these services and cannot use grants to replace existing state/local spending.
This bill, the Conscience Protection Act of 2025, strengthens protections for healthcare providers and organizations that refuse to participate in certain medical procedures (including abortion, assisted suicide, and sterilization) based on religious, moral, or ethical beliefs. It creates a private right of action allowing affected entities to seek legal remedies when their conscience rights are violated, addressing a gap in current law where victims could not defend their rights in court. The bill amends the Public Health Service Act to prohibit discrimination against such healthcare entities and establishes clearer enforcement mechanisms through the Department of Health and Human Services, including administrative investigations and civil actions. It directly affects healthcare providers, hospitals, insurers, and other health-related organizations operating under federal funding. The bill aims to address inconsistent enforcement of existing conscience protections like the Weldon Amendment, which has been challenged in cases such as California's abortion coverage mandate.
This bill reauthorizes three existing rural health care grant programs under the Public Health Service Act through 2030, extending funding from the previous 2021-2025 period. It requires all funded projects to directly serve rural underserved populations and involve these communities in planning, development, and operations. The programs support rural clinics, health networks, and quality improvement initiatives to expand access to care in underserved areas. Funding will now continue through 2030, maintaining critical support for rural health providers.
